2022 |
09/01 | 4,530 | 4,552 | 4,520 | 4,526 | -0.77% | 660,400 | 2兆5247億 | -2.69% |
08/31 | 4,509 | 4,570 | 4,509 | 4,561 | +0.62% | 1,282,900 | 2兆5442億 | -2.25% |
08/30 | 4,555 | 4,586 | 4,528 | 4,533 | -0.37% | 677,300 | 2兆5286億 | -3.12% |
08/29 | 4,531 | 4,561 | 4,509 | 4,550 | -1.11% | 781,000 | 2兆5381億 | -3.11% |
08/26 | 4,597 | 4,633 | 4,588 | 4,601 | +0.17% | 463,700 | 2兆5666億 | -2.36% |
08/25 | 4,605 | 4,619 | 4,567 | 4,593 | +0.17% | 621,600 | 2兆5621億 | -2.83% |
08/24 | 4,604 | 4,614 | 4,557 | 4,585 | -1.46% | 730,600 | 2兆5576億 | -3.29% |
08/23 | 4,724 | 4,728 | 4,633 | 4,653 | -1.84% | 906,400 | 2兆5956億 | -2.08% |
08/22 | 4,709 | 4,753 | 4,654 | 4,740 | +1.56% | 861,100 | 2兆6441億 | -0.46% |
08/19 | 4,705 | 4,715 | 4,662 | 4,667 | -0.98% | 730,100 | 2兆6034億 | -2.16% |
08/18 | 4,713 | 4,722 | 4,664 | 4,713 | -0.13% | 1,138,300 | 2兆6290億 | -1.42% |
08/17 | 4,668 | 4,732 | 4,650 | 4,719 | +0.53% | 1,018,600 | 2兆6324億 | -1.48% |
08/16 | 4,713 | 4,722 | 4,662 | 4,694 | -0.68% | 656,200 | 2兆6184億 | -2.21% |
08/15 | 4,685 | 4,740 | 4,682 | 4,726 | +0.81% | 563,900 | 2兆6363億 | -1.71% |
08/12 | 4,689 | 4,716 | 4,665 | 4,688 | +1.49% | 1,293,700 | 2兆6151億 | -2.72% |
08/10 | 4,655 | 4,670 | 4,582 | 4,619 | -0.54% | 1,019,000 | 2兆5766億 | -4.35% |
08/09 | 4,677 | 4,708 | 4,628 | 4,644 | -0.77% | 841,000 | 2兆5905億 | -4.05% |
08/08 | 4,635 | 4,693 | 4,622 | 4,680 | +0.45% | 744,800 | 2兆6106億 | -3.49% |
08/05 | 4,611 | 4,664 | 4,600 | 4,659 | +1.53% | 1,188,800 | 2兆5989億 | -4% |
08/04 | 4,719 | 4,719 | 4,554 | 4,589 | +0.22% | 1,239,400 | 2兆5599億 | -5.56% |
08/03 | 4,648 | 4,648 | 4,562 | 4,579 | +0.53% | 1,265,200 | 2兆5543億 | -5.94% |
08/02 | 4,670 | 4,681 | 4,550 | 4,555 | -3.86% | 1,045,800 | 2兆5409億 | -6.7% |
08/01 | 4,722 | 4,770 | 4,711 | 4,738 | -0.34% | 1,013,300 | 2兆6430億 | -3.15% |
07/29 | 13:30 2022年12月期第2四半期決算短信〔IFRS〕(連結) |
07/29 | 4,944 | 4,948 | 4,691 | 4,754 | -3.04% | 1,710,200 | 2兆6519億 | -2.66% |
07/28 | 4,899 | 4,920 | 4,826 | 4,903 | +0.14% | 1,241,900 | 2兆7350億 | +0.57% |
07/27 | 4,866 | 4,913 | 4,786 | 4,896 | +0.18% | 1,530,800 | 2兆7311億 | +0.76% |
07/26 | 16:00 Paradise超音波腎デナベーションシステム高血圧患者対象のRADIANCE-II米国ピボタル試験にて主要評価項目を達成 |
07/26 | 16:00 業績予想の修正に関するお知らせ |
07/26 | 4,942 | 4,958 | 4,876 | 4,887 | -1.39% | 792,900 | 2兆7261億 | +0.97% |
07/25 | 4,955 | 4,990 | 4,923 | 4,956 | +0.08% | 665,100 | 2兆7646億 | +2.8% |
07/22 | 4,976 | 4,983 | 4,900 | 4,952 | -0.52% | 797,300 | 2兆7624億 | +3.23% |
07/21 | 4,902 | 4,987 | 4,899 | 4,978 | +0.79% | 840,900 | 2兆7769億 | +4.27% |
07/20 | 4,906 | 4,949 | 4,879 | 4,939 | +1.56% | 955,300 | 2兆7551億 | +4.04% |
07/19 | 4,902 | 4,914 | 4,838 | 4,863 | -1.1% | 645,500 | 2兆7127億 | +2.92% |
07/15 | 4,941 | 4,966 | 4,898 | 4,917 | -0.43% | 866,000 | 2兆7428億 | +4.42% |
07/14 | 4,910 | 4,960 | 4,875 | 4,938 | +0.2% | 915,300 | 2兆7545億 | +5.31% |
07/13 | 4,937 | 4,976 | 4,915 | 4,928 | -0.36% | 809,400 | 2兆7490億 | +5.52% |
07/12 | 4,954 | 4,985 | 4,924 | 4,946 | -0.76% | 1,058,400 | 2兆7590億 | +6.37% |
07/11 | 4,949 | 5,000 | 4,920 | 4,984 | +2.15% | 1,163,900 | 2兆7802億 | +7.72% |
07/08 | 4,950 | 4,962 | 4,832 | 4,879 | -2.42% | 1,593,500 | 2兆7216億 | +6.02% |
07/07 | 4,972 | 5,000 | 4,923 | 5,000 | +1.32% | 1,391,000 | 2兆7891億 | +9.15% |
07/06 | 4,867 | 4,964 | 4,860 | 4,935 | +0.8% | 1,508,200 | 2兆7529億 | +8.39% |
07/05 | 4,881 | 4,896 | 4,830 | 4,896 | +0.29% | 1,055,000 | 2兆7311億 | +8.06% |
07/04 | 4,900 | 4,929 | 4,840 | 4,882 | +2.37% | 1,104,400 | 2兆7233億 | +8.32% |
07/01 | 4,858 | 4,904 | 4,753 | 4,769 | -1.02% | 1,080,500 | 2兆6603億 | +6.28% |
06/30 | 4,815 | 4,861 | 4,811 | 4,818 | +0.27% | 1,439,500 | 2兆6876億 | +7.81% |
06/29 | 4,850 | 4,878 | 4,793 | 4,805 | -2.63% | 1,703,800 | 2兆6804億 | +7.95% |
06/28 | 4,809 | 4,950 | 4,797 | 4,935 | +2.88% | 1,611,700 | 2兆7529億 | +11.27% |
06/27 | 4,567 | 4,805 | 4,518 | 4,797 | +5.38% | 2,104,900 | 2兆6759億 | +8.6% |
06/27 | 9:00 抗精神病薬「ブレクスピプラゾール」アルツハイマー型認知症に伴う行動障害を対象としたグローバルフェーズ3試験で主要評価項目を達成し有効性を確認 |
06/24 | 4,560 | 4,565 | 4,499 | 4,552 | +0.6% | 702,600 | 2兆5392億 | +3.34% |
06/23 | 4,490 | 4,554 | 4,490 | 4,525 | +0.67% | 754,300 | 2兆5242億 | +2.82% |
06/22 | 4,465 | 4,517 | 4,453 | 4,495 | +1.33% | 735,100 | 2兆5074億 | +2.18% |
06/21 | 4,430 | 4,462 | 4,379 | 4,436 | +0.66% | 904,200 | 2兆4745億 | +0.8% |
06/20 | 4,413 | 4,447 | 4,380 | 4,407 | +1.08% | 552,200 | 2兆4583億 | +0.11% |
06/17 | 17:30 アリピプラゾール2ヵ月持続性注射剤統合失調症の適応で欧州医薬品庁が申請受理 |
06/17 | 4,322 | 4,388 | 4,307 | 4,360 | 0% | 1,339,700 | 2兆4321億 | -0.95% |
06/16 | 4,378 | 4,415 | 4,358 | 4,360 | +1.14% | 704,000 | 2兆4321億 | -0.91% |
06/15 | 4,394 | 4,395 | 4,306 | 4,311 | -1.64% | 764,400 | 2兆4048億 | -2.07% |
06/14 | 4,406 | 4,426 | 4,366 | 4,383 | -1.66% | 862,500 | 2兆4449億 | -0.52% |
06/13 | 4,381 | 4,464 | 4,381 | 4,457 | +0.47% | 835,800 | 2兆4862億 | +1.09% |
06/10 | 4,474 | 4,474 | 4,424 | 4,436 | -0.65% | 1,085,100 | 2兆4745億 | +0.64% |
06/09 | 4,450 | 4,492 | 4,431 | 4,465 | +0.81% | 865,800 | 2兆4907億 | +1.22% |
06/08 | 4,396 | 4,433 | 4,365 | 4,429 | +1.72% | 796,600 | 2兆4706億 | +0.43% |
06/07 | 4,330 | 4,379 | 4,320 | 4,354 | -0.25% | 801,400 | 2兆4288億 | -1.2% |
06/06 | 4,320 | 4,376 | 4,316 | 4,365 | +0.55% | 732,600 | 2兆4349億 | -0.82% |
06/03 | 4,342 | 4,368 | 4,321 | 4,341 | +0.56% | 771,000 | 2兆4215億 | -1.27% |
06/02 | 4,375 | 4,383 | 4,304 | 4,317 | -1.48% | 954,300 | 2兆4081億 | -1.73% |
06/01 | 4,340 | 4,432 | 4,324 | 4,382 | +2.17% | 1,198,600 | 2兆4444億 | -0.18% |
05/31 | 4,391 | 4,422 | 4,289 | 4,289 | -2.01% | 5,562,700 | 2兆3925億 | -2.19% |
05/30 | 4,349 | 4,410 | 4,330 | 4,377 | +1.06% | 1,250,000 | 2兆4416億 | -0.07% |
05/27 | 4,400 | 4,409 | 4,313 | 4,331 | -0.57% | 889,400 | 2兆4159億 | -0.89% |
05/26 | 4,409 | 4,441 | 4,354 | 4,356 | -1.6% | 1,167,200 | 2兆4299億 | -0.14% |
05/25 | 4,475 | 4,482 | 4,426 | 4,427 | -0.9% | 978,000 | 2兆4695億 | +1.63% |
05/24 | 4,498 | 4,509 | 4,462 | 4,467 | -0.8% | 819,300 | 2兆4918億 | +2.71% |
05/23 | 4,490 | 4,522 | 4,453 | 4,503 | +1.4% | 1,019,700 | 2兆5119億 | +3.8% |
05/20 | 4,474 | 4,494 | 4,435 | 4,441 | -0.98% | 1,392,100 | 2兆4773億 | +2.68% |
05/19 | 4,423 | 4,503 | 4,395 | 4,485 | -1.43% | 1,135,400 | 2兆5018億 | +3.89% |
05/18 | 4,486 | 4,555 | 4,478 | 4,550 | +2.32% | 1,412,700 | 2兆5381億 | +5.64% |
05/17 | 4,461 | 4,474 | 4,415 | 4,447 | +0.57% | 1,416,400 | 2兆4806億 | +3.56% |
05/16 | 4,350 | 4,504 | 4,350 | 4,422 | +2.46% | 1,095,400 | 2兆4667億 | +3.22% |
05/13 | 13:30 大塚製薬とアケビア社の腎性貧血治療薬におけるグローバルライセンス契約の終了について |
05/13 | 13:30 2022年12月期第1四半期決算短信〔IFRS〕(連結) |
05/13 | 4,400 | 4,420 | 4,250 | 4,316 | -1.82% | 1,840,300 | 2兆4076億 | +0.91% |
05/12 | 4,396 | 4,417 | 4,339 | 4,396 | -0.57% | 855,800 | 2兆4522億 | +2.83% |
05/11 | 4,406 | 4,450 | 4,401 | 4,421 | -0.45% | 895,000 | 2兆4661億 | +3.58% |
05/10 | 4,424 | 4,451 | 4,405 | 4,441 | +0.05% | 870,800 | 2兆4773億 | +4.22% |
05/09 | 4,495 | 4,506 | 4,419 | 4,439 | -1.86% | 936,900 | 2兆4762億 | +4.35% |
05/06 | 4,444 | 4,532 | 4,411 | 4,523 | +2.26% | 1,517,200 | 2兆5230億 | +6.5% |
05/02 | 4,351 | 4,430 | 4,303 | 4,423 | +1.38% | 1,225,600 | 2兆4673億 | +4.41% |
04/28 | 16:00 譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ |
04/28 | 4,233 | 4,376 | 4,191 | 4,363 | +4% | 1,398,100 | 2兆4338億 | +3.17% |
04/27 | 4,239 | 4,239 | 4,165 | 4,195 | -1.99% | 1,497,700 | 2兆3401億 | -0.71% |
04/26 | 4,245 | 4,303 | 4,237 | 4,280 | +0.87% | 1,065,800 | 2兆3875億 | +1.23% |
04/25 | 4,217 | 4,254 | 4,195 | 4,243 | +0.24% | 742,900 | 2兆3668億 | +0.5% |
04/22 | 4,228 | 4,243 | 4,198 | 4,233 | -0.4% | 713,100 | 2兆3613億 | +0.33% |
04/21 | 4,215 | 4,282 | 4,173 | 4,250 | +1.8% | 895,500 | 2兆3708億 | +0.83% |
04/20 | 4,122 | 4,177 | 4,110 | 4,175 | +1.14% | 670,900 | 2兆3289億 | -0.74% |
04/19 | 4,134 | 4,151 | 4,108 | 4,128 | +0.29% | 553,700 | 2兆3027億 | -1.67% |
04/18 | 4,171 | 4,184 | 4,081 | 4,116 | -2.37% | 514,900 | 2兆2960億 | -1.77% |
04/15 | 4,203 | 4,236 | 4,174 | 4,216 | -0.57% | 475,400 | 2兆3518億 | +0.81% |
04/14 | 4,193 | 4,258 | 4,190 | 4,240 | +0.98% | 481,800 | 2兆3652億 | +1.61% |
04/13 | 4,126 | 4,213 | 4,125 | 4,199 | +0.53% | 856,900 | 2兆3423億 | +0.96% |
04/12 | 4,221 | 4,235 | 4,168 | 4,177 | -1.44% | 707,300 | 2兆3300億 | +0.8% |
04/11 | 4,230 | 4,247 | 4,202 | 4,238 | +0.02% | 810,600 | 2兆3641億 | +2.54% |
04/08 | 4,282 | 4,282 | 4,228 | 4,237 | -0.09% | 1,332,000 | 2兆3635億 | +2.81% |
04/07 | 4,180 | 4,248 | 4,159 | 4,241 | +1.41% | 934,800 | 2兆3657億 | +3.21% |